Evaluation of the Clinical, Laboratory and Imaging Findings of Patients with COVID-19 and Their Associations with Clinical Outcomes in an Iranian Hospital: A Cross-Sectional Study
Novelty in Biomedicine,
Vol. 9 No. 4 (2021),
12 November 2021
,
Page 165-170
https://doi.org/10.22037/nbm.v9i4.32667
Abstract
Background: Coronavirus disease 2019 (COVID-19) is a concern in the medical community as the virus spreads around the world. It has a heavy global burden, particularly in low-income countries. This virus has its specific outcomes in each population. Hence, it is necessary to design studies to find the epidemiological behaviour of this virus.Materials and Methods: This cross-sectional study was conducted in the Labbafinezhad hospital, Tehran, Iran. Demographic features include age, sex, past medical history, drug history, habitual file, influenza vaccination history, recent exposure history, clinical symptoms or signs, and the recorded symptoms. The clinical examination and para-clinical assessment, including chest computed tomography (CT) and laboratory testing on admission, were recorded.
Results: It was found that patients with a history of kidney transplantation, high level of LDH, high level of AST, and increased neutrophil to lymphocyte ratio are most at risk of death.
Conclusion: Parameters mentioned could help practitioners predict patient outcomes, and necessary interventions could be considered in this regard.
- COVID-19, SARS-CoV-2, Epidemiological study, Coronavirus
How to Cite
References
Chatterjee P, Nagi N, Agarwal A, Das B, Banerjee S, Sarkar S, et al. The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence. The Indian journal of medical research. 2020;151(2-3):147.
Organization WH. Coronavirus disease ( COVID-19): situation report, 166. 2020.
Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems. Infection Control & Hospital Epidemiology. 2020;41(6):754-5.
Trilla A. One world, one health: The novel coronavirus COVID-19 epidemic. Medicina clinica (English ed). 2020;154(5):175.
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? International journal of epidemiology. 2020;49(3):717-26.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020;323(13):1239-42.
Lee I, Wang C, Lin M, Kung C, Lan K, Lee C. Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital. The Journal of hospital infection. 2020;105(1):102.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine. 2020;172(9):577-82.
Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A, Hashemian SM. A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol. Iranian Journal of Pharmaceutical Research: IJPR. 2020;19(1):31.
Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55(4):105932.
Rosa SGV, Santos WC. Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana de Salud Pública. 2020;44:e40.
Sri IGAAP, Marzuki JE, Angelia F, Siane A, Sary LD, Yohanes L, et al. Antiviral treatment of COVID-19: a clinical pharmacology narrative review. Medical Journal of Indonesia. 2020;29(3):332-45.
Organization WH. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance2020. p. 21-.
Organization WH. Home care for patients with suspected novel coronavirus ( COVID-19) infection presenting with mild symptoms, and management of their contacts: interim guidance, February 04 2020. World Health Organization; 2020.
- Abstract Viewed: 226 times
- pdf Downloaded: 253 times